BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33528822)

  • 1. Gene therapy in color vision deficiency: a review.
    El Moussawi Z; Boueiri M; Al-Haddad C
    Int Ophthalmol; 2021 May; 41(5):1917-1927. PubMed ID: 33528822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations in the gene for α-subunit of retinal cone cyclic nucleotide-gated channels in a Japanese patient with congenital achromatopsia.
    Kuniyoshi K; Muraki-Oda S; Ueyama H; Toyoda F; Sakuramoto H; Ogita H; Irifune M; Yamamoto S; Nakao A; Tsunoda K; Iwata T; Ohji M; Shimomura Y
    Jpn J Ophthalmol; 2016 May; 60(3):187-97. PubMed ID: 27040408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of
    Ofri R; Averbukh E; Ezra-Elia R; Ross M; Honig H; Obolensky A; Rosov A; Hauswirth WW; Gootwine E; Banin E
    Hum Gene Ther; 2018 Dec; 29(12):1376-1386. PubMed ID: 29926749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy for Color Blindness.
    Hassall MM; Barnard AR; MacLaren RE
    Yale J Biol Med; 2017 Dec; 90(4):543-551. PubMed ID: 29259520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia.
    Banin E; Gootwine E; Obolensky A; Ezra-Elia R; Ejzenberg A; Zelinger L; Honig H; Rosov A; Yamin E; Sharon D; Averbukh E; Hauswirth WW; Ofri R
    Mol Ther; 2015 Sep; 23(9):1423-33. PubMed ID: 26087757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel CNGA3 and CNGB3 mutations in two Pakistani families with achromatopsia.
    Azam M; Collin RW; Shah ST; Shah AA; Khan MI; Hussain A; Sadeque A; Strom TM; Thiadens AA; Roosing S; den Hollander AI; Cremers FP; Qamar R
    Mol Vis; 2010 Apr; 16():774-81. PubMed ID: 20454696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial.
    Fischer MD; Michalakis S; Wilhelm B; Zobor D; Muehlfriedel R; Kohl S; Weisschuh N; Ochakovski GA; Klein R; Schoen C; Sothilingam V; Garcia-Garrido M; Kuehlewein L; Kahle N; Werner A; Dauletbekov D; Paquet-Durand F; Tsang S; Martus P; Peters T; Seeliger M; Bartz-Schmidt KU; Ueffing M; Zrenner E; Biel M; Wissinger B
    JAMA Ophthalmol; 2020 Jun; 138(6):643-651. PubMed ID: 32352493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics and Disease Expression in the CNGA3 Form of Achromatopsia: Steps on the Path to Gene Therapy.
    Zelinger L; Cideciyan AV; Kohl S; Schwartz SB; Rosenmann A; Eli D; Sumaroka A; Roman AJ; Luo X; Brown C; Rosin B; Blumenfeld A; Wissinger B; Jacobson SG; Banin E; Sharon D
    Ophthalmology; 2015 May; 122(5):997-1007. PubMed ID: 25616768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cone cGMP-gated channel mutations and clinical findings in patients with achromatopsia, macular degeneration, and other hereditary cone diseases.
    Nishiguchi KM; Sandberg MA; Gorji N; Berson EL; Dryja TP
    Hum Mutat; 2005 Mar; 25(3):248-58. PubMed ID: 15712225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of the achromatopsia genes CNGA3 and CNGB3 in progressive cone dystrophy.
    Thiadens AA; Roosing S; Collin RW; van Moll-Ramirez N; van Lith-Verhoeven JJ; van Schooneveld MJ; den Hollander AI; van den Born LI; Hoyng CB; Cremers FP; Klaver CC
    Ophthalmology; 2010 Apr; 117(4):825-30.e1. PubMed ID: 20079539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Retinal Structure in ATF6-Associated Achromatopsia.
    Mastey RR; Georgiou M; Langlo CS; Kalitzeos A; Patterson EJ; Kane T; Singh N; Vincent A; Moore AT; Tsang SH; Lin JH; Young MP; Hartnett ME; Héon E; Kohl S; Michaelides M; Carroll J
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2631-2640. PubMed ID: 31237654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achromatopsia as a potential candidate for gene therapy.
    Pang JJ; Alexander J; Lei B; Deng W; Zhang K; Li Q; Chang B; Hauswirth WW
    Adv Exp Med Biol; 2010; 664():639-46. PubMed ID: 20238068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Achromatopsia Mouse Model Resulting From a Naturally Occurring Missense Change in Cngb3.
    Hassall MM; Barnard AR; Orlans HO; McClements ME; Charbel Issa P; Aslam SA; MacLaren RE
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):6102-6110. PubMed ID: 30592498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligocone trichromacy: clinical and molecular genetic investigations.
    Andersen MK; Christoffersen NL; Sander B; Edmund C; Larsen M; Grau T; Wissinger B; Kohl S; Rosenberg T
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):89-95. PubMed ID: 19797231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and Clinical Characterization of
    Amaral RAS; Motta FL; Zin OA; da Palma MM; Rodrigues GD; Sallum JMF
    Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia.
    Pang JJ; Deng WT; Dai X; Lei B; Everhart D; Umino Y; Li J; Zhang K; Mao S; Boye SL; Liu L; Chiodo VA; Liu X; Shi W; Tao Y; Chang B; Hauswirth WW
    PLoS One; 2012; 7(4):e35250. PubMed ID: 22509403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreal delivery of AAV vectored Cnga3 restores cone function in CNGA3-/-/Nrl-/- mice, an all-cone model of CNGA3 achromatopsia.
    Du W; Tao Y; Deng WT; Zhu P; Li J; Dai X; Zhang Y; Shi W; Liu X; Chiodo VA; Ding XQ; Zhao C; Michalakis S; Biel M; Zhang Z; Qu J; Hauswirth WW; Pang JJ
    Hum Mol Genet; 2015 Jul; 24(13):3699-707. PubMed ID: 25855802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy Evaluation of rAAV2tYF-PR1.7-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep.
    Gootwine E; Ofri R; Banin E; Obolensky A; Averbukh E; Ezra-Elia R; Ross M; Honig H; Rosov A; Yamin E; Ye GJ; Knop DR; Robinson PM; Chulay JD; Shearman MS
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):96-107. PubMed ID: 28478700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy restores missing cone-mediated vision in the CNGA3-/- mouse model of achromatopsia.
    Michalakis S; Mühlfriedel R; Tanimoto N; Krishnamoorthy V; Koch S; Fischer MD; Becirovic E; Bai L; Huber G; Beck SC; Fahl E; Büning H; Schmidt J; Zong X; Gollisch T; Biel M; Seeliger MW
    Adv Exp Med Biol; 2012; 723():183-9. PubMed ID: 22183332
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy.
    Carvalho LS; Xu J; Pearson RA; Smith AJ; Bainbridge JW; Morris LM; Fliesler SJ; Ding XQ; Ali RR
    Hum Mol Genet; 2011 Aug; 20(16):3161-75. PubMed ID: 21576125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.